SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001274644-14-000025
Filing Date
2014-11-13
Accepted
2014-11-13 17:02:31
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ocera3q-201410q.htm 10-Q 874508
2 FIRST AMENDMENT TO THE LEASE AGREEMENT DATED AUGUST 29, 2014 ocrxexhibit1012014.htm EX-10.1 19457
3 CERTIFICATION OF CEO ocrxexhibit3113q2014.htm EX-31.1 16579
4 CERTIFICATION OF CFO ocrxexhibit3123q2014.htm EX-31.2 16563
5 CONTROL CERTIFICATION OF CEO ocrxexhibit3213q2014.htm EX-32.1 7545
6 CONTROL CERTIFICATION OF CFO ocrxexhibit3223q2014.htm EX-32.2 7527
  Complete submission text file 0001274644-14-000025.txt   6672768

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ocrx-20140930.xml EX-101.INS 1184647
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocrx-20140930.xsd EX-101.SCH 27385
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ocrx-20140930_cal.xml EX-101.CAL 67737
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ocrx-20140930_def.xml EX-101.DEF 157809
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocrx-20140930_lab.xml EX-101.LAB 478229
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocrx-20140930_pre.xml EX-101.PRE 278680
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35119 | Film No.: 141219141
SIC: 2834 Pharmaceutical Preparations